523 related articles for article (PubMed ID: 31478113)
41. Magnetic resonance imaging-transrectal ultrasound fusion image-guided prostate biopsy: Current status of the cancer detection and the prospects of tailor-made medicine of the prostate cancer.
Shoji S
Investig Clin Urol; 2019 Jan; 60(1):4-13. PubMed ID: 30637355
[TBL] [Abstract][Full Text] [Related]
42. Risk-based Patient Selection for Magnetic Resonance Imaging-targeted Prostate Biopsy after Negative Transrectal Ultrasound-guided Random Biopsy Avoids Unnecessary Magnetic Resonance Imaging Scans.
Alberts AR; Schoots IG; Bokhorst LP; van Leenders GJ; Bangma CH; Roobol MJ
Eur Urol; 2016 Jun; 69(6):1129-34. PubMed ID: 26651990
[TBL] [Abstract][Full Text] [Related]
43. Prospective assessment of two-gene urinary test with multiparametric magnetic resonance imaging of the prostate for men undergoing primary prostate biopsy.
Busetto GM; Del Giudice F; Maggi M; De Marco F; Porreca A; Sperduti I; Magliocca FM; Salciccia S; Chung BI; De Berardinis E; Sciarra A
World J Urol; 2021 Jun; 39(6):1869-1877. PubMed ID: 32681273
[TBL] [Abstract][Full Text] [Related]
44. Can multiparametric magnetic resonance of the prostate avoid biopsies in patients with elevated PSA and surgical indication for benign prostatic enlargement?
Wroclawski ML; Kayano PP; Amaral BS; Mariotti GC; Yamauchi FI; Cha JD; Carneiro A; Korkes F; Vitalli AS; Mussi TC; Lemos GC; Baroni RH
Abdom Radiol (NY); 2020 Oct; 45(10):3278-3282. PubMed ID: 31974659
[TBL] [Abstract][Full Text] [Related]
45. Confirmatory biopsy of men under active surveillance: extended versus saturation versus multiparametric magnetic resonance imaging/transrectal ultrasound fusion prostate biopsy.
Pepe P; Cimino S; Garufi A; Priolo G; Russo GI; Giardina R; Reale G; Pennisi M; Morgia G
Scand J Urol; 2017 Aug; 51(4):260-263. PubMed ID: 28513296
[TBL] [Abstract][Full Text] [Related]
46. MRI-targeted or systematic random biopsies for prostate cancer diagnosis in biopsy naïve patients: follow-up of a PRECISION trial-like retrospective cohort.
Luzzago S; de Cobelli O; Mistretta FA; Piccinelli ML; Lorusso V; Morelli M; Bianchi R; Catellani M; Cozzi G; Di Trapani E; Pricolo P; Alessi S; Ferro M; Marvaso G; Matei DV; Jereczek-Fossa BA; Petralia G; Musi G
Prostate Cancer Prostatic Dis; 2021 Jun; 24(2):406-413. PubMed ID: 32989259
[TBL] [Abstract][Full Text] [Related]
47. Utilization trend of prebiopsy multiparametric magnetic resonance imaging and its impact on prostate cancer detection: Real-world insights from a high-volume center in southwest China.
Zhang C; Tu X; Dai J; Zhang Z; Shen C; Wu Q; Liu Z; Lin T; Qiu S; Yang L; Yang L; Zhang M; Cai D; Bao Y; Zeng H; Wei Q
Prostate; 2024 May; 84(6):539-548. PubMed ID: 38173301
[TBL] [Abstract][Full Text] [Related]
48. Nonsuspicious prebiopsy multiparametric MRI: is prostate biopsy still necessary?
Anastay V; Gondran-Tellier B; McManus R; Delonca R; Akiki A; Gaillet S; Delaporte V; Andre M; Daniel L; Karsenty G; Lechevallier E; Boissier R; Baboudjian M
Abdom Radiol (NY); 2020 Dec; 45(12):4160-4165. PubMed ID: 32902661
[TBL] [Abstract][Full Text] [Related]
49. The current role of prostate multiparametric magnetic resonance imaging.
Rouviere O; Moldovan PC
Asian J Urol; 2019 Apr; 6(2):137-145. PubMed ID: 31061799
[TBL] [Abstract][Full Text] [Related]
50. Can 3-Tesla pelvic phased-array multiparametric MRI avoid unnecessary repeat prostate biopsy in patients with PSA < 10 ng/mL?
Pepe P; Garufi A; Priolo G; Pennisi M
Clin Genitourin Cancer; 2015 Feb; 13(1):e27-30. PubMed ID: 25081324
[TBL] [Abstract][Full Text] [Related]
51. MRI/US fusion-guided biopsy: performing exclusively targeted biopsies for the early detection of prostate cancer.
Del Monte M; Leonardo C; Salvo V; Grompone MD; Pecoraro M; Stanzione A; Campa R; Vullo F; Sciarra A; Catalano C; Panebianco V
Radiol Med; 2018 Mar; 123(3):227-234. PubMed ID: 29075977
[TBL] [Abstract][Full Text] [Related]
52. Multiparametric MRI and MRI/TRUS Fusion Guided Biopsy for the Diagnosis of Prostate Cancer.
Schütz V; Kesch C; Dieffenbacher S; Bonekamp D; Hadaschik BA; Hohenfellner M; Radtke JP
Adv Exp Med Biol; 2018; 1096():87-98. PubMed ID: 30324349
[TBL] [Abstract][Full Text] [Related]
53. Incidence of significant prostate cancer after negative MRI and systematic biopsy in the FUTURE trial.
Exterkate L; Wegelin O; Barentsz JO; van der Leest MG; Kummer JA; Vreuls W; de Bruin PC; Witjes JA; van Melick HHE; Somford DM
BJU Int; 2023 Mar; 131(3):313-320. PubMed ID: 35993590
[TBL] [Abstract][Full Text] [Related]
54. A prospective study investigating the impact of multiparametric MRI in biopsy-naïve patients with clinically suspected prostate cancer: The PROKOMB study.
Baur ADJ; Henkel T; Johannsen M; Speck T; Weißbach L; Hamm B; König F
Contemp Clin Trials; 2017 May; 56():46-51. PubMed ID: 28279782
[TBL] [Abstract][Full Text] [Related]
55. The role of gadolinium in magnetic resonance imaging for early prostate cancer diagnosis: A diagnostic accuracy study.
Cosma I; Tennstedt-Schenk C; Winzler S; Psychogios MN; Pfeil A; Teichgraeber U; Malich A; Papageorgiou I
PLoS One; 2019; 14(12):e0227031. PubMed ID: 31869380
[TBL] [Abstract][Full Text] [Related]
56. MRI ultrasound fusion biopsy in prostate cancer detection: Are randomized clinical trials reproducible in everyday clinical practice?
Cattarino S; Forte V; Salciccia S; Drudi FM; Cantisani V; Sciarra A; Fasulo A; Ciccariello M
Urologia; 2019 Feb; 86(1):9-16. PubMed ID: 30890102
[TBL] [Abstract][Full Text] [Related]
57. Integration and Diagnostic Accuracy of 3T Nonendorectal coil Prostate Magnetic Resonance Imaging in the Context of Active Surveillance.
Curci NE; Lane BR; Shankar PR; Noyes SL; Moriarity AK; Kubat A; Brede C; Montgomery JS; Auffenberg GB; Miller DC; Montie JE; George AK; Davenport MS
Urology; 2018 Jun; 116():137-143. PubMed ID: 29653121
[TBL] [Abstract][Full Text] [Related]
58. Cancer detection rate of prebiopsy MRI with subsequent systematic and targeted biopsy are superior to non-targeting systematic biopsy without MRI in biopsy naïve patients: a retrospective cohort study.
Washino S; Kobayashi S; Okochi T; Kameda T; Konoshi T; Miyagawa T; Takayama T; Morita T
BMC Urol; 2018 May; 18(1):51. PubMed ID: 29843694
[TBL] [Abstract][Full Text] [Related]
59. Assessment of free-hand transperineal targeted prostate biopsy using multiparametric magnetic resonance imaging-transrectal ultrasound fusion in Chinese men with prior negative biopsy and elevated prostate-specific antigen.
Lian H; Zhuang J; Wang W; Zhang B; Shi J; Li D; Fu Y; Jiang X; Zhou W; Guo H
BMC Urol; 2017 Jul; 17(1):52. PubMed ID: 28679370
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of Transperineal Magnetic Resonance Imaging/Ultrasound-Fusion Biopsy Compared to Transrectal Systematic Biopsy in the Prediction of Tumour Aggressiveness in Patients with Previously Negative Biopsy.
Borkowetz A; Renner T; Platzek I; Toma M; Herout R; Baunacke M; Groeben C; Huber J; Laniado M; Baretton G; Froehner M; Zastrow S; Wirth MP
Urol Int; 2019; 102(1):20-26. PubMed ID: 30149386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
